INTERFERON ALFA-2B IN THE MANAGEMENT OF CHRONIC GRANULOCYTIC-LEUKEMIA

被引：6

作者：

BERGSAGEL, DE

机构：

来源：

CANCER TREATMENT REVIEWS | 1988年 / 15卷

关键词：

D O I：

10.1016/0305-7372(88)90069-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：15 / 20

页数：6

共 11 条

[1]

ALLAN NC, 1978, LANCET, V2, P523

[2]

BERGSAGEL DE, 1987, INVEST NEW DRUG, V5, pS9

[3]

CANNELLOS GP, 1977, CLIN HAEMATOL, V6, P113

[4] TREATMENT OF THE CHRONIC LEUKAEMIAS [J].

GALTON, DAG .

BRITISH MEDICAL BULLETIN, 1959, 15 (01) :78-85

[5]

GALTON DAG, 1977, RECENT ADV HAEMATOLO, V2, P219

[6]

GOLDMAN JM, 1978, SEMIN HEMATOL, V15, P420

[7]

HILL NO, 1982, P AM SOC CLIN ONCO C, V1, P499

[8]

TAETLE R, 1980, BLOOD, V56, P549

[9] SUPPRESSION OF CLONAL EVOLUTION IN 2 CHRONIC MYELOGENOUS LEUKEMIA PATIENTS TREATED WITH LEUKOCYTE INTERFERON [J].

TALPAZ, M ;

TRUJILLO, JM ;

HITTELMAN, WN ;

KEATING, MJ ;

GUTTERMAN, JU .

BRITISH JOURNAL OF HAEMATOLOGY, 1985, 60 (04) :619-624

[10] HEMATOLOGIC REMISSION AND CYTOGENETIC IMPROVEMENT INDUCED BY RECOMBINANT HUMAN INTERFERON-ALPHA-A IN CHRONIC MYELOGENOUS LEUKEMIA [J].

TALPAZ, M ;

KANTARJIAN, HM ;

MCCREDIE, K ;

TRUJILLO, JM ;

KEATING, MJ ;

GUTTERMAN, JU .

NEW ENGLAND JOURNAL OF MEDICINE, 1986, 314 (17) :1065-1069

← 1 2 →